Post-meal blood sugar spikes may increase Alzheimer’s risk

A large genetic study has found that sharp rises in blood sugar after meals could significantly heighten the risk of Alzheimer’s disease. Researchers from the University of Liverpool analyzed data from over 350,000 UK Biobank participants, revealing a 69% increased risk linked to postprandial hyperglycemia. The effect appears independent of visible brain damage, pointing to subtler biological mechanisms.

Researchers at the University of Liverpool have uncovered evidence that post-meal blood sugar spikes may pose a greater threat to brain health than previously recognized. In a study published in Diabetes, Obesity and Metabolism in 2025, the team examined genetic and health data from more than 350,000 participants in the UK Biobank, all aged between 40 and 69. The analysis targeted metrics like fasting glucose, insulin levels, and blood sugar two hours after eating, employing Mendelian randomization to determine causal links to dementia.

The results highlighted a strong association between elevated post-meal glucose—termed postprandial hyperglycemia—and Alzheimer’s disease. Participants with higher levels faced a 69% greater risk, a connection not attributable to brain atrophy or white matter lesions. This suggests underlying pathways, possibly involving hidden metabolic effects, that warrant further investigation.

Conditions like type 2 diabetes and insulin resistance have long been tied to cognitive decline, but this research isolates after-meal spikes as a distinct factor. Lead author Dr. Andrew Mason noted, "This finding could help shape future prevention strategies, highlighting the importance of managing blood sugar not just overall, but specifically after meals."

Senior author Dr. Vicky Garfield emphasized the need for validation: "We first need to replicate these results in other populations and ancestries to confirm the link and better understand the underlying biology. If validated, the study could pave the way for new approaches to reduce dementia risk in people with diabetes."

These insights build on prior knowledge of hyperglycemia's role in dementia, potentially informing targeted interventions to safeguard brain health amid rising diabetes rates.

Связанные статьи

Conceptual illustration of gut bacteria producing inflammatory glycogen triggering brain inflammation in C9orf72-linked ALS and FTD, with stool sample comparisons and mouse treatment outcomes.
Изображение, созданное ИИ

Study links microbial glycogen in the gut to inflammation in C9orf72-associated ALS and frontotemporal dementia

Сообщено ИИ Изображение, созданное ИИ Проверено фактами

Researchers at Case Western Reserve University report that some gut bacteria can make unusually inflammatory forms of glycogen and that this microbial glycogen can trigger immune activity linked to brain inflammation in models of disease tied to the C9orf72 mutation. In patient stool samples, the team found these glycogen forms more often in ALS and C9orf72-related frontotemporal dementia than in healthy controls, and enzymatically breaking down glycogen in the gut improved outcomes in mice.

New research from the University of Southern California suggests that subtle declines in brain blood flow and oxygen delivery may be early indicators of Alzheimer's disease. The study, published in Alzheimer's and Dementia, used noninvasive scans to connect vascular health with amyloid plaques and hippocampal shrinkage. These findings highlight the role of brain circulation in the disease process beyond traditional markers like amyloid and tau.

Сообщено ИИ

Older adults carrying high-risk APOE4 gene variants experienced slower cognitive decline and lower dementia risk with higher meat consumption, according to a Karolinska Institutet study of over 2,100 participants tracked for up to 15 years. Findings suggest diet's effects on brain health vary by genetics, challenging one-size-fits-all advice.

A study of over 375,000 Finns has linked hospital treatment for severe infections like cystitis and pneumonia to a higher risk of developing dementia within five to six years. Researchers identified 29 conditions associated with at least a 20 percent increased risk, with infections playing a key role. The findings suggest that preventing such infections could help modify dementia risk.

Сообщено ИИ Проверено фактами

Researchers from the Institute for Bioengineering of Catalonia and collaborating institutions report that engineered “supramolecular” nanoparticles restored aspects of blood-brain barrier function in Alzheimer’s-model mice, rapidly lowering brain amyloid-β and producing improvements on behavioral and memory tests.

Этот сайт использует куки

Мы используем куки для анализа, чтобы улучшить наш сайт. Прочитайте нашу политику конфиденциальности для дополнительной информации.
Отклонить